NECC May Have Broken State Licensing Laws
The compounding pharmacy at the center of the nationwide meningitis outbreak may have been violating state operating laws, regulatory officials have stated.
Representatives from the Massachusetts Bureau of Health Care Safety and Quality recently released a statement accusing the pharmacy of operating more like a pharmaceutical company than a compounding pharmacy.
The pharmacy has been accused of producing tainted vials of the steroidal back injection Methylprednisolone Acetate which has been linked to a nationwide fungal meningitis outbreak.
Pharmacy Shipped Mass Quantities of Tainted Drug
Compounding pharmacies are different from traditional pharmacies in that they produce special order medications for clinics and doctors. New England Compounding Pharmacy (NECC) was only authorized to make specialized medications is response to a doctor’s prescription for an individual patient. Instead, the pharmacy was mass producing medications and sending them to pain clinics in several states.
“[The] pharmacy license did not allow it to ship large quantities for general use,” Michigan Attorney General Bill Schuette said.
Several States Investigating New England Compounding Pharmacy
A number of states, including Indiana, Minnesota, Ohio, Tennessee, and New Hampshire, have all taken actions to investigate NECC. In some states, NECC could face criminal charges if found guilty of violating licensing laws.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively.
If you or someone you love contracted fungal meningitis after being injected with Methylprednisolone Acetate produced at New England Compounding Pharmacy, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.